XR iPSC-Derived Cerebral Organoid Differentiation Kit

Description

Generating human cerebral organoids from induced pluripotent stem cells can be affected by uneven embryoid body formation, variable neural induction, inconsistent extracellular matrix embedding, and insufficient nutrient exchange during long-term three-dimensional culture. These variables may influence organoid size, optical density, neural tissue expansion, and the formation of cortical-like regions.

XR Cerebral Organoid Differentiation Kit is a chemically defined, four-stage culture system designed to differentiate human pluripotent stem cells, including human induced pluripotent stem cells and human embryonic stem cells, into three-dimensional cerebral organoids. The staged workflow guides cultures through embryoid body formation, neural induction, neural tissue expansion, matrix-supported growth, and orbital maturation.

The resulting hPSC-derived cerebral organoids can develop into large, optically dense structures containing multiple neural lineages and observable cortical-like regions. This human brain organoid culture system provides researchers with a structured workflow for studying early human cortical development and characterizing three-dimensional neural tissue formation.

Each kit contains four stage-specific cerebral organoid media and supports the generation of approximately 48 organoids when used according to the recommended workflow.

Specifications

Kit Components

Features

• Four-stage cerebral organoid differentiation workflow designed for human pluripotent stem cells

• Chemically defined culture system for controlled stage-specific neural differentiation

• Supports embryoid body formation in low-attachment U-bottom plates

• Guides cultures through neural induction, matrix embedding, neural expansion, and long-term maturation

• Designed to generate large, optically dense human cerebral organoids

• Supports the development of multiple neural lineages and observable cortical-like regions

• Includes sufficient stage-specific media for approximately 48 cerebral organoids

• Compatible with extended orbital culture at 65–75 rpm from Day 14 onward

• Suitable for iPSC cerebral organoid and hESC cerebral organoid research workflows

Cerebral Organoid Differentiation Workflow

The recommended protocol begins with healthy human pluripotent stem cell cultures at approximately 80% confluency. Cells are dissociated into single cells before sequential exposure to the four stage-specific media.

Performance and Characterization Data

Progressive Three-Dimensional Organoid Formation

The source data show a staged morphological transition from adherent iPSC culture to compact embryoid bodies, followed by neural induction, neural tissue expansion, and formation of a large cerebral organoid. The Day 40+ morphology demonstrates the continued three-dimensional growth supported by the maturation medium and orbital culture stage.

Neural and Cortical Marker Expression

Immunofluorescence images provided with the kit show expression of neural development-associated markers, including TUJ, PAX6, CTIP2, and FOXG1. Together, these markers are used to characterize neuronal differentiation, neural progenitor populations, cortical neuronal development, and forebrain-associated identity within the generated organoids.

Applications

XR Cerebral Organoid Differentiation Kit is intended for research workflows requiring a three-dimensional human neural model derived from pluripotent stem cells. The four-stage system supports experimental designs focused on organoid generation, early neural differentiation, cortical-like tissue organization, and characterization of hPSC-derived brain tissue.

• Human cerebral organoid generation: Differentiation of human iPSCs or hESCs into three-dimensional cerebral organoids through an EB-based workflow.

• Early human brain development research: Study of cellular and structural changes associated with early neural and cerebral tissue development in vitro.

• Cortical development studies: Investigation of cortical-like region formation and expression of development-associated markers such as PAX6 and CTIP2.

• Forebrain development research: Generation and characterization of neural tissue expressing the forebrain-associated marker FOXG1.

• Neural induction studies: Evaluation of the transition from pluripotent stem cells and embryoid bodies toward neuroectodermal and neural progenitor populations.

• Neuronal differentiation research: Characterization of neuronal development and TUJ-positive structures in a three-dimensional organoid environment.

• Human iPSC line comparison: Comparison of cerebral organoid formation between different human induced pluripotent stem cell lines under a common staged protocol.

• Gene function research: Phenotypic characterization of genetically modified hPSC lines during cerebral organoid differentiation.

• Organoid morphology analysis: Assessment of EB formation, optical density, neural tissue expansion, organoid size, and structural development over time.

• Long-term neural organoid culture: Continued orbital culture beyond Day 40 for studies requiring larger or more developed cerebral organoids.

• Three-dimensional neural model research: Use of hPSC-derived cerebral organoids as in vitro 3D brain models for basic neurodevelopmental research.

• Neural marker characterization: Immunofluorescence analysis of markers associated with neurons, neural progenitors, cortical neurons, and forebrain identity.

Key Workflow Considerations

Starting Cell Quality

Begin differentiation with healthy, actively growing hPSC cultures at approximately 80% confluency. Cultures showing substantial spontaneous differentiation, low viability, or irregular colony morphology may produce less consistent embryoid bodies.

Single-Cell Dissociation

Consistent single-cell preparation is important for generating uniform EBs in the 96-well low-attachment U-bottom plate. Excessive mechanical stress or prolonged dissociation may reduce cell viability and affect early aggregate formation.

Extracellular Matrix Embedding

During Days 11–13, developing organoids are embedded in an extracellular matrix gel. Consistent matrix volume, handling temperature, and positioning can help reduce variation in neural tissue expansion between organoids.

Orbital Culture

From Day 14 onward, orbital culture at 65–75 rpm supports medium movement around the developing organoids. Shaker speed, plate position, working volume, and medium replacement schedule should remain consistent throughout the maturation phase.

Why Choose XR Cerebral Organoid Differentiation Kit?

Cerebral organoid generation is a multistage process in which variation during EB formation, neural induction, matrix embedding, or maturation can affect the final organoid phenotype. Researchers therefore require more than a general neural differentiation medium; they need a coordinated workflow that supports each developmental stage with the appropriate culture environment.

XR Cerebral Organoid Differentiation Kit provides four stage-specific media organized around the major steps of human cerebral organoid culture. The workflow begins with controlled embryoid body formation and progresses through neural induction, matrix-supported expansion, and long-term orbital maturation. This structure helps laboratories standardize the timing and medium transitions used during iPSC cerebral organoid differentiation.

The kit also provides sufficient medium to generate approximately 48 organoids and includes characterization data for TUJ, PAX6, CTIP2, and FOXG1 expression. It is therefore suitable for laboratories developing reproducible hPSC-derived cerebral organoid workflows for early human neural and cortical development research.

FAQ

For Research Use Only. Not for use in diagnostic or therapeutic procedures.